October 17, 2013 / 4:19 PM / 4 years ago

Belgium's Gimv sells remaining Ablynx stake

BRUSSELS (Reuters) - Belgian investment fund Gimv (GIMV.BR) said it sold its remaining stake in biotech firm Ablynx (ABLX.BR) after partnering the company for 12 years.

Gimv said the exit has a positive impact of 3.8 million euros on its last published equity value, and it would use the proceeds to make other investments in the biotech sector.

Reporting by Robert-Jan Bartunek

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below